Bunge
BG
105.51
-1.82
-1.70%
Bunge
US · BG
#907 by market cap
Listed 1970
105.51
-1.82
-1.70%
Live - 5344 symbols - heartbeat 548s ago
· 2026-10-08 08:08
Pre-market
105.96
+0.43%
After-hours
105.75
+0.23%
Overnight
105.51
0.00%
- Market cap
- 20.27B
- P/E (TTM)i
- 22.84
- P/Bi
- 1.27
- EPSi
- 4.91
- Div yieldi
- 2.67%
- 52W posi
- 50%
Reader sentiment
Are you bullish or bearish on BG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.79, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +32.43% YoY
Margins
- Gross margin
- 4.85%
- Operating margin
- 1.84%
- Net margin
- 1.16%
Key ratios & quality
- Enterprise valuei
- 32.82B
- Altman Z-Scorei
- 2.79
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 45.74B | 41.14B | 41.40B | 59.15B | 67.23B | 59.54B | 53.11B | 70.33B |
| Gross profit | 2.27B | 542.00M | 2.79B | 3.36B | 3.68B | 4.85B | 3.39B | 3.41B |
| Selling & admin expenses | 1.42B | 1.35B | 1.36B | 1.23B | 1.37B | 1.72B | 1.78B | 2.11B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 843.00M | -809.00M | 1.43B | 2.13B | 2.31B | 3.13B | 1.62B | 1.30B |
| Pretax profit | 456.00M | -1.21B | 1.41B | 2.57B | 2.07B | 3.05B | 1.52B | 1.13B |
| Tax | 179.00M | 86.00M | 248.00M | 398.00M | 388.00M | 714.00M | 336.00M | 288.00M |
| Net profit | 287.00M | -1.29B | 1.17B | 2.17B | 1.68B | 2.34B | 1.19B | 843.00M |
| Basic EPS | 2 | -9 | 8 | 15 | 11 | 15 | 8 | 5 |
| Diluted EPS | 1.64 | -9.34 | 7.71 | 13.64 | 10.51 | 14.87 | 7.99 | 4.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 11.64B | 12.77B | 22.16B | 23.76B | 21.86B | 24.04B |
| Gross profit | 597.00M | 738.00M | 1.06B | 1.01B | 766.00M | 1.68B |
| Selling & admin expenses | 380.00M | 418.00M | 678.00M | 637.00M | 531.00M | 606.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 217.00M | 320.00M | 385.00M | 374.00M | 235.00M | 1.08B |
| Pretax profit | 284.00M | 494.00M | 270.00M | 86.00M | 61.00M | 943.00M |
| Tax | 80.00M | 124.00M | 86.00M | -2.00M | -14.00M | 236.00M |
| Net profit | 204.00M | 370.00M | 181.00M | 88.00M | 75.00M | 707.00M |
| Basic EPS | 2 | 3 | 1 | 0 | 0 | 4 |
| Diluted EPS | 1.48 | 2.61 | 0.84 | 0.49 | 0.35 | 3.47 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 11.07B | 10.25B | 16.18B | 16.46B | 16.76B | 16.35B | 15.96B | 24.39B |
| Cash & ST investments | 551.00M | 713.00M | 698.00M | 1.42B | 1.22B | 2.71B | 3.80B | 2.20B |
| Inventory | 5.87B | 5.04B | 7.17B | 8.43B | 8.41B | 7.11B | 6.49B | 13.20B |
| Total assets | 19.43B | 18.32B | 23.66B | 23.82B | 24.58B | 25.37B | 24.90B | 44.53B |
| Total current liabilities | 7.17B | 6.60B | 10.99B | 9.32B | 9.60B | 7.69B | 7.44B | 15.13B |
| Short-term debt | 1.17B | 1.49B | 3.07B | 1.53B | 1.82B | 1.11B | 1.83B | 5.93B |
| Long-term debt | 4.20B | 3.72B | 4.45B | 4.79B | 3.26B | 4.08B | 4.69B | 8.83B |
| Total liabilities | 12,623,000,000.00 | 11,890,000,000.00 | 17,035,000,000.00 | 15,613,000,000.00 | 14,620,000,000.00 | 13,557,000,000.00 | 13,950,000,000.00 | 27,106,000,000.00 |
| Total equity | 6.80B | 6.43B | 6.62B | 8.21B | 9.96B | 11.82B | 10.95B | 17.42B |
| Retained earnings | 8.06B | 6.44B | 7.24B | 8.98B | 10.22B | 12.08B | 12.84B | 13.15B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 17.37B | 21.45B | 26.72B | 24.39B | 27.09B | 26.22B |
| Cash & ST investments | 3.88B | 7.14B | 3.71B | 2.20B | 1.70B | 833.00M |
| Inventory | 7.82B | 8.01B | 13.31B | 13.20B | 15.43B | 15.46B |
| Total assets | 26.66B | 31.15B | 46.30B | 44.53B | 47.58B | 46.78B |
| Total current liabilities | 8.54B | 10.38B | 16.10B | 15.13B | 16.94B | 16.73B |
| Short-term debt | 2.29B | 4.51B | 6.82B | 5.93B | 5.21B | 6.34B |
| Long-term debt | 4.71B | 7.04B | 9.81B | 8.83B | 9.95B | 9.43B |
| Total liabilities | 15,067,000,000.00 | 19,198,000,000.00 | 29,007,000,000.00 | 27,106,000,000.00 | 30,099,000,000.00 | 29,372,000,000.00 |
| Total equity | 11.59B | 11.96B | 17.29B | 17.42B | 17.48B | 17.41B |
| Retained earnings | 13.03B | 13.01B | 13.05B | 13.15B | 13.22B | 13.34B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -1.26B | -808.00M | -3.54B | -2.89B | -5.55B | 3.31B | 1.90B | 844.00M |
| Depreciation & amortization | 622.00M | 548.00M | 435.00M | 424.00M | 408.00M | 451.00M | 468.00M | 703.00M |
| Free cash flow | -1.76B | -1.33B | -3.90B | -3.29B | -6.10B | 2.19B | 524.00M | -879.00M |
| Dividends paid | -305.00M | -317.00M | -316.00M | -323.00M | -349.00M | -383.00M | -378.00M | -459.00M |
| Stock buybacks / issuance | 0 | 0 | -100.00M | -100.00M | -200.00M | -600.00M | -1.10B | -551.00M |
| Ending cash balance | 393.00M | 322.00M | 381.00M | 905.00M | 1.15B | 2.62B | 3.33B | 1.17B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -285.00M | -1.07B | 854.00M | 1.35B | -541.00M | -585.00M |
| Depreciation & amortization | 120.00M | 116.00M | 241.00M | 226.00M | 238.00M | 256.00M |
| Free cash flow | -595.00M | -1.48B | 385.00M | 809.00M | -877.00M | -1.03B |
| Dividends paid | -91.00M | -94.00M | -139.00M | -135.00M | -136.00M | -139.00M |
| Stock buybacks / issuance | -- | -- | -545.00M | -6.00M | -- | -- |
| Ending cash balance | 3.25B | 6.81B | 1.33B | 1.17B | 847.00M | 596.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 3.90 | -24.70 | 21.15 | 33.08 | 19.87 | 22.35 | 10.95 | 6.32 |
| ROA %i | 1.22 | -7.01 | 5.34 | 8.61 | 6.65 | 8.98 | 4.52 | 2.35 |
| ROIC %i | 3.81 | -10.05 | 10.81 | 16.19 | 13.12 | 16.05 | 8.19 | 4.65 |
| 5-year avg ROE %i | 6.78 | 0.74 | 2.78 | 7.08 | 10.66 | 14.35 | 21.48 | 18.51 |
| EBIT margin %i | 1.74 | -2.11 | 4.05 | 4.75 | 3.67 | 5.99 | 3.76 | 2.51 |
| FCF / sales %i | -- | -- | -- | -- | -- | 3.67 | 0.99 | -- |
| Current ratioi | 1.54 | 1.55 | 1.47 | 1.77 | 1.75 | 2.13 | 2.15 | 1.61 |
| Quick ratioi | 0.39 | 0.44 | 0.26 | 0.42 | 0.47 | 0.75 | 0.88 | 0.46 |
| Debt / assetsi | 27.66 | 31.39 | 34.26 | 28.63 | 22.88 | 22.69 | 28.59 | 35.61 |
| LT debt / equityi | 76.66 | 81.47 | 93.57 | 75.84 | 41.26 | 42.82 | 53.35 | 62.42 |
| Interest coveragei | 2.35 | -2.55 | 6.33 | 11.56 | 6.13 | 6.91 | 4.24 | 2.81 |
| Revenue CAGR (3Y) %i | 1.73 | -1.22 | -3.30 | 8.95 | 17.79 | 12.87 | -3.53 | 1.51 |
| Net income CAGR (3Y) %i | -30.37 | -- | 92.71 | 98.17 | -- | 25.12 | -18.21 | -20.27 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.36 | 13.20 | 10.22 | 6.32 | 5.13 | 7.50 |
| ROA %i | 4.17 | 4.96 | 3.70 | 2.35 | 1.84 | 2.58 |
| ROIC %i | 7.60 | 8.11 | 6.17 | 4.65 | 4.31 | 5.30 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 3.71 | 4.48 | 3.83 | 2.51 | 2.01 | 2.35 |
| FCF / sales %i | -- | -- | -- | -- | -- | -- |
| Current ratioi | 2.04 | 2.07 | 1.66 | 1.61 | 1.60 | 1.57 |
| Quick ratioi | 0.79 | 0.96 | 0.51 | 0.46 | 0.39 | 0.33 |
| Debt / assetsi | 28.74 | 39.20 | 38.40 | 35.61 | 34.24 | 36.03 |
| LT debt / equityi | 50.79 | 70.81 | 69.51 | 62.42 | 69.07 | 65.96 |
| Interest coveragei | 4.08 | 5.07 | 4.39 | 2.81 | 2.29 | 2.71 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Soybean Processing and Refining is the largest reported line at 51.21% of revenue, across 6 reported segments.
- Grain Merchandising and Milling follows at 30.84%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Soybean Processing and Refining51.21%
Grain Merchandising and Milling30.84%
Softseed Processing and Refining18.53%
Tropical Oils and Specialty Ingredients5.63%
Quote time 2026-10-08 08:08:13 · For reference only, not investment advice and not tailored to your situation.